Study of fatty liver inflammation in Chinese children
Part of Digestive system clinical trials.
This trial looks at nonalcoholic steatohepatitis (fatty liver with inflammation) in children. It is meant to test whether a new approach can help improve this liver problem without being caused by alcohol or other known liver diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 1 to 18 years old
- A liver biopsy has already confirmed fatty liver with inflammation
- Your alcohol intake is very low (under 20 g/day for boys and under 10 g/day for girls)
- You do not have viral hepatitis (like hepatitis B or C)
- You do not have other specific liver diseases (like autoimmune hepatitis, Wilson disease, or alpha-1 antitrypsin disease)
- Your liver issues are not mainly caused by medicines (drug-related liver injury)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how liver scarring (fibrosis) and fat buildup (steatosis) change over time in people with nonalcoholic fatty liver disease (NAFLD). It helps doctors understand risk factors so they can better predict and manage the disease.
This is a registry study collecting information about children and teens with fatty liver disease that isn’t caused by alcohol. It aims to better understand this condition and may help future research and treatments.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
This study follows people who have been confirmed to have fatty liver disease seen on a liver sample. It aims to understand the condition over time and how different causes and health factors may affect it.
This study tracks the progression of fatty liver disease and NASH in Chinese patients. It aims to better understand how the condition develops over time, which may help improve future treatments and care.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.